Tenax Therapeutics to Present Phase 3 LEVEL Trial Results at ESC Congress 2026

Tenax Therapeutics announced it will showcase late-breaking scientific data from its Phase 3 LEVEL clinical trial during upcoming sessions at the European Society of Cardiology Congress.

29 Aug, 12:21 — 29 Aug, 12:21

Post Share

Sources

Showing 1 of 1 sources

taiwan-newsMostly Factual21h ago

Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 - Taiwan News

Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 Taiwan News

Read full article →

Tenax Therapeutics to Present Phase 3 LEVEL Trial Results at ESC Congress 2026

Sources

Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 - Taiwan News

Related Stories

Russia Escalates Gray Zone Operations Across Europe Amid Rising Tensions

Malaysia Increases Subsidized Fuel Quotas Ahead of Independence Day

Record-Breaking White Falcon Sells for Dh1.5 Million at Abu Dhabi Auction

Vietnamese Coffee Farmers Pivot to Durian Exports for China